Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marlys L Koschinsky

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 23, 2013
Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesteroneMathieu Garand, Joellen H H Lin, Branislava Zagorac, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 27, 2002
Apolipoprotein(a) phenotype and lipoprotein(a) level predict peritoneal dialysis patient mortalityEduard A Iliescu, Santica M Marcovina, Alexander R Morton, et al.
Journal of Clinical Lipidology|September 21, 2024
Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in AfricansDaniel Bruwer, Zelda de Lange-Loots, Marlys L Koschinsky, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2022
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB SecretionAmer Youssef, Justin R Clark, Santica M Marcovina, et al.
Progress in Lipid Research|September 11, 2017
The renaissance of lipoprotein(a): Brave new world for preventive cardiology?Katrina L Ellis, Michael B Boffa, Amirhossein Sahebkar, et al.
The Journal of Biological Chemistry|April 17, 2003
Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfacesMark A Hancock, Michael B Boffa, Santica M Marcovina, et al.
The Journal of Biological Chemistry|October 23, 2004
Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9Caroline H O'Neil, Michael B Boffa, Mark A Hancock, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|May 20, 2003
Identification of a novel apolipoprotein(a)-related protein from the European hedgehog (Erinaceus europaeus)Andrea R Belczewski, P Michel Laplaud, M John Chapman, et al.
Biochemistry|January 23, 2002
Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10Mona N Rahman, Lev Becker, Vitali Petrounevitch, et al.
The Journal of Biological Chemistry|May 10, 2002
A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitorMichael B Boffa, Jeffrey D Hamill, Nazareth Bastajian, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 23, 2013
Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesteroneMathieu Garand, Joellen H H Lin, Branislava Zagorac, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 27, 2002
Apolipoprotein(a) phenotype and lipoprotein(a) level predict peritoneal dialysis patient mortalityEduard A Iliescu, Santica M Marcovina, Alexander R Morton, et al.
Journal of Clinical Lipidology|September 21, 2024
Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in AfricansDaniel Bruwer, Zelda de Lange-Loots, Marlys L Koschinsky, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 20, 2022
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB SecretionAmer Youssef, Justin R Clark, Santica M Marcovina, et al.
Progress in Lipid Research|September 11, 2017
The renaissance of lipoprotein(a): Brave new world for preventive cardiology?Katrina L Ellis, Michael B Boffa, Amirhossein Sahebkar, et al.
The Journal of Biological Chemistry|April 17, 2003
Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfacesMark A Hancock, Michael B Boffa, Santica M Marcovina, et al.
The Journal of Biological Chemistry|October 23, 2004
Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9Caroline H O'Neil, Michael B Boffa, Mark A Hancock, et al.
DNA Sequence : the Journal of DNA Sequencing and Mapping|May 20, 2003
Identification of a novel apolipoprotein(a)-related protein from the European hedgehog (Erinaceus europaeus)Andrea R Belczewski, P Michel Laplaud, M John Chapman, et al.
Biochemistry|January 23, 2002
Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10Mona N Rahman, Lev Becker, Vitali Petrounevitch, et al.
The Journal of Biological Chemistry|May 10, 2002
A role for CCAAT/enhancer-binding protein in hepatic expression of thrombin-activable fibrinolysis inhibitorMichael B Boffa, Jeffrey D Hamill, Nazareth Bastajian, et al.
Pageof 13